Search research articles
Contact Us
Filters
Showing results (91-100 of 152) with videos related to
Page
of 16
Sort By:
Clinical Rheumatology
|
April 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022
Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
The American Journal of Medicine
|
July 1, 1997
Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome
U Vollmer-Conna, I Hickie, D Hadzi-Pavlovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 15, 1993
The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation
I Kola, S Brookes, A R Green, et al.
The Journal of Rheumatology
|
March 3, 2015
Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia
Abir Bhattacharyya, Joanne Sahhar, Sam Milliken, et al.
Gene
|
July 18, 2002
Human aminopeptidase B (rnpep) on chromosome 1q32.2: complementary DNA, genomic structure and expression
Christophe Piesse, Martin Tymms, Emirena Garrafa, et al.
Oncogene
|
June 12, 1997
ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter
R S Thomas, M J Tymms, L H McKinlay, et al.
Biochimica Et Biophysica Acta
|
August 2, 2003
The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome
E W Wolvetang, O M Bradfield, M Tymms, et al.
Molecular Reproduction and Development
|
January 1, 1996
Construction of a mouse blastocyst cDNA library by PCR amplification from total RNA
C M Corrick, M J Silvestro, M H Lahoud, et al.
Clinical Endocrinology
|
September 1, 1999
Kallmann's syndrome: is it always for life?
R Quinton, H K Cheow, D J Tymms, et al.
The Journal of Rheumatology
|
December 3, 2019
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset
Peter Youssef, Bruno Marcal, Peter Button, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 152) with videos related to
Sort By:
Page
of 16
Clinical Rheumatology
|
April 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022
Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan, et al.
The American Journal of Medicine
|
July 1, 1997
Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome
U Vollmer-Conna, I Hickie, D Hadzi-Pavlovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 15, 1993
The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation
I Kola, S Brookes, A R Green, et al.
The Journal of Rheumatology
|
March 3, 2015
Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia
Abir Bhattacharyya, Joanne Sahhar, Sam Milliken, et al.
Gene
|
July 18, 2002
Human aminopeptidase B (rnpep) on chromosome 1q32.2: complementary DNA, genomic structure and expression
Christophe Piesse, Martin Tymms, Emirena Garrafa, et al.
Oncogene
|
June 12, 1997
ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter
R S Thomas, M J Tymms, L H McKinlay, et al.
Biochimica Et Biophysica Acta
|
August 2, 2003
The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome
E W Wolvetang, O M Bradfield, M Tymms, et al.
Molecular Reproduction and Development
|
January 1, 1996
Construction of a mouse blastocyst cDNA library by PCR amplification from total RNA
C M Corrick, M J Silvestro, M H Lahoud, et al.
Clinical Endocrinology
|
September 1, 1999
Kallmann's syndrome: is it always for life?
R Quinton, H K Cheow, D J Tymms, et al.
The Journal of Rheumatology
|
December 3, 2019
Reasons for Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drug Cessation and Persistence of Second-line Treatment in a Rheumatoid Arthritis Dataset
Peter Youssef, Bruno Marcal, Peter Button, et al.
Page
of 16